Select for export Biophotons, hallucinogens, and fluorescence Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0924-9338(11)72907-8 Copy citation Copy BibTeX European Psychiatry 2011-02-28 F. Grass OpenAlex Published psilocin Pharmacology Other More
Select for export The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.biopsych.2010.10.002 PubMed 21126732 Copy citation Copy BibTeX Biological Psychiatry 2010-12-02 Kometer M, Cahn BR, Andel D, Carter OL, Vollenweider FX. Europe PMC Published psilocybin Receptor PharmacologyConsciousness Other More
Select for export Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0014074 PubMed 21152030 Copy citation Copy BibTeX PLoS ONE 2010-12-01 Matthew J. Baggott, Jennifer D. Siegrist, Gantt P. Galloway, Lynn C. Robertson, Jeremy Coyle, John Mendelson OpenAlex Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Randomized Controlled Trial More
Select for export Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/archgenpsychiatry.2010.116 PubMed 20819978 Copy citation Copy BibTeX Archives of General Psychiatry 2010-09-05 Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL Europe PMC Published psilocybin DepressionAnxietyAging Other More
Select for export Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines No abstract availability was recorded for this entry. Details DOI 10.1007/s00213-008-1356-8 PubMed 18979087 Copy citation Copy BibTeX Psychopharmacology 2008-10-30 J.C. Winter OpenAlex Published psilocybin PharmacologyReceptor PharmacologyToxicity Other More
Select for export Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder No abstract availability was recorded for this entry. Details DOI 10.1016/s0084-3970(08)70820-x Copy citation Copy BibTeX Yearbook of Psychiatry and Applied Mental Health 2007-12-31 J.C. Ballenger OpenAlex Published psilocybin OCDPharmacologySafety Other More
Select for export Psilocybin Results Inspire Researchers No abstract availability was recorded for this entry. Details DOI 10.1016/s0270-6644(07)70405-8 Copy citation Copy BibTeX Clinical Psychiatry News 2007-06-30 TIMOTHY F. KIRN OpenAlex Published psilocybin General Other More
Select for export Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.4088/jcp.v67n1110 PubMed 17196053 Copy citation Copy BibTeX The Journal of Clinical Psychiatry 2006-10-31 Moreno FA, Wiegand CB, Taitano EK, Delgado PL. Europe PMC Published psilocybin AnxietyOCDChronic Pain Other More
Select for export Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/s-2005-916185 PubMed 16342002 Copy citation Copy BibTeX Pharmacopsychiatry 2005-10-31 Gouzoulis-Mayfrank E, Heekeren K, Neukirch A, Stoll M, Stock C, Obradovic M Europe PMC Published psilocybin Receptor PharmacologyHealthy Volunteers Other More
Select for export Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/s-2005-918695 Copy citation Copy BibTeX Pharmacopsychiatry 2005-08-31 Euphrosyne Gouzoulis-Mayfrank, Anna Neukirch, Karsten Heekeren OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Other More
Select for export Hallucinogen persisting perception disorder after psilocybin consumption: a case study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.eurpsy.2005.04.008 PubMed 15963699 Copy citation Copy BibTeX European Psychiatry 2005-07-31 Espiard ML, Lecardeur L, Abadie P, Halbecq I, Dollfus S. Europe PMC Published psilocybin DepressionAnxietyAddiction Other More
Select for export Designer Hallucinogens Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/00132981-200312000-00015 Copy citation Copy BibTeX Emergency Medicine News 2003-11-30 Leon Gussow OpenAlex Published psilocybin DepressionReceptor PharmacologyToxicity Other More
Select for export Effects of a Psychedelic, Tropical Tea, Ayahuasca, on the Electroencephalographic (EEG) Activity of the Human Brain during a Shamanistic Ritual Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Unknown journal 2000-12-31 Erik Hoffmann, Jan M. Keppel Hesselink, M. da Silveira Barbosa OpenAlex Published psilocybin Brain ImagingReceptor PharmacologyConsciousness Other More
Select for export 177. NMDA and 5-HT2A receptor dysfunction in working memory deficits in schizophrenia No abstract availability was recorded for this entry. Details DOI 10.1016/s0006-3223(00)00439-x Copy citation Copy BibTeX Biological Psychiatry 2000-03-31 Daniel Umbricht, F.X. Vollenweider, L. Schmid, R. Koller OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export Microcrystalloptic tests for lysergic acid diethylamide and other hallucinogens Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/j.2042-7158.1970.tb08449.x PubMed 4395800 Copy citation Copy BibTeX Journal of Pharmacy and Pharmacology 1970-10-31 K. Genest, Lorna J. Lowry OpenAlex Published psilocybinpsilocin Receptor PharmacologyToxicity Other More
Select for export Psilocybin-Induced Transformations of Visual Space Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/s-0028-1094281 Copy citation Copy BibTeX Pharmacopsychiatry 1970-06-30 Richard Hill, Roland A. Fischer OpenAlex Published psilocybin PharmacologyReceptor PharmacologyToxicity Other More
Select for export Hypnotic Induction of the Interference of Psilocybin with Optically Induced Spatial Distortion Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/s-0028-1094250 Copy citation Copy BibTeX Pharmacopsychiatry 1969-10-31 Peter Gwynne, Roland Fischer, Richard Hill OpenAlex Published psilocybin PharmacologyReceptor PharmacologyPersonality Change Other More
Select for export Psilocybin-induced Autonomic, Perceptual, and Behavioral Change Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/s-0028-1094227 Copy citation Copy BibTeX Pharmacopsychiatry 1968-10-31 R Fischer, Diana Warshay OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Other More
Select for export Dynamics of Psychedelic Drug Abuse Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/archpsyc.1967.01730230044006 PubMed 5337259 Copy citation Copy BibTeX Archives of General Psychiatry 1967-04-30 Malcolm B. Bowers OpenAlex Published psilocybin Receptor PharmacologyToxicity Other More
Select for export CLINICAL OBSERVATIONS OF SIMULTANEOUS HALLUCINOGEN ADMINISTRATION IN IDENTICAL TWINS Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/ajp.118.9.815 PubMed 14007020 Copy citation Copy BibTeX American Journal of Psychiatry 1962-02-28 Bernard Wilkens, Sidney Malitz, Harold Esecover OpenAlex Published psilocybin Personality Change Other More